Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Medicure Inc
V.MPH
Alternate Symbol(s):
MCUJF
Healthcare
Drug Manufacturers - Specialty & Generic
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with...
primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (TSXV:MPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(107)
•••
Checkout
X
Post by
Checkout
on Oct 14, 2025 1:34pm
Medicure Inc. ($MPH.V) – Deep Value in Plain Sight
While most microcaps are chasing hype, Medicure is quietly building real value. Trading at just 0.6x Price-to-Sales, it’s one of the most undervalued specialty pharma plays on the TSXV. Compare that
...more
(107)
•••
Checkout
X
Post by
Checkout
on Oct 09, 2025 9:03am
It has been a long wait, but when you can smell smoke,
fire is not far behind.
Scaling for long-term success: A new era in gold development
posted Dec 11, 2025 9:00am by
Vista Gold Corp.
-
|
Backed by years of technical expertise and strategic discipline, Mt Todd has emerged as one of the most compelling undeveloped gold assets globally. A recently completed feasibility study signals a pivotal shift in strategy ...read more
(107)
•••
Checkout
X
Post by
Checkout
on Oct 09, 2025 8:54am
Solar energy named the worlds cheapest power source
https://www.msn.com/en-ca/money/topstories/solar-energy-named-the-world-s-cheapest-power-source-what-it-means-for-europe/ar-AA1O3J9M?ocid=msedgntp&pc=HCTS&cvid=68e6e9db9a0e4826b81f2c2f669ffaed
...more
(9)
•••
Winnipeg40
X
Comment by
Winnipeg40
on Sep 27, 2025 2:10pm
RE:RE:RE:you obviously have personal issues to resolve
beacuse I am NOT wrong
(9)
•••
Winnipeg40
X
Comment by
Winnipeg40
on Sep 27, 2025 2:09pm
RE:Medicure correction of Comments made.
You should look at prior years where if one carefully reads the notes, the Birmingham Royalties were not paid for several quarters and no mention of breach and there certainly have not been showing of
...more
(9)
•••
invest92
X
Post by
invest92
on Sep 24, 2025 11:44am
MEDICURE ANNOUNCES UPDATE MEND-PNPO PHASE3
https://www.medicure.com/press-releases/medicure-announces-update-on-enrollment-in-its-mend-pnpo-phase-3-clinical-trial-and-presentation-of-the-trial-design-and-baseline-data-at-the-2025-child
...more
(107)
•••
Checkout
X
Comment by
Checkout
on Sep 24, 2025 11:35am
RE:RE:you obviously have personal issues to resolve
How can you be so wrong and not apologize to this thread and Medicure for your blatant misrepresentation of the facts. Perhaps you should not post lies in an attempt to affect my investment
...more
(107)
•••
Checkout
X
Comment by
Checkout
on Sep 23, 2025 10:04am
RE:Medicure correction of Comments made.
Thanks for the detailed post Kruiseship. Hopefully that is where the next shareholder meeting will be.
(2)
•••
Kruisip
X
Post by
Kruisip
on Sep 22, 2025 11:36am
Medicure correction of Comments made.
Off late I have seen some wrong opinions, based on superficial analysis. It concerns supposed missed payments for the acquisition of Zydal and not reported or paid royalties for Zydal
...more
(107)
•••
Checkout
X
Post by
Checkout
on Sep 20, 2025 11:09am
the only problem is
if they stop taking the drug, they have a seizure.
(107)
•••
Checkout
X
Post by
Checkout
on Sep 20, 2025 11:07am
Don' forget this Claude, this is what may be worth 100m+
PNPO deficiency, MC1 is essentially providing the exact active substance that these patients are missing. The Link Between PNPO Deficiency and MC1
...more
(3)
•••
Claude5555
X
Comment by
Claude5555
on Sep 20, 2025 8:04am
RE:Medicure (MPH.V): Deep Value in Plain Sight
Very good information, thanks
(107)
•••
Checkout
X
Post by
Checkout
on Sep 18, 2025 1:28pm
Medicure (MPH.V): Deep Value in Plain Sight
Current Price: $1.10 CAD Fair Value Estimate: $3.41 CAD (per Simply Wall St DCF model) Price-to-Sales Ratio: 0.6x vs. peer average of 8.2x Medicure is trading at a fraction
...more
(107)
•••
Checkout
X
Post by
Checkout
on Sep 18, 2025 1:26pm
Let’s be real—
Medicure is trading like a microcap with no growth story, yet its fundamentals tell a different tale: Revenue up 29% YoY in Q2 2025, driven by ZYPITAMAG and Marley Drug
...more
(107)
•••
Checkout
X
Post by
Checkout
on Sep 17, 2025 10:30am
RE: Let’s not confuse skepticism with certainty
I appreciate the deep dive into the financials—scrutiny is healthy. But let’s be clear: Medicure’s acquisition of Zypitamag from Zydus was publicly disclosed with a structured payment plan, including
...more
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Mt Todd has emerged as one of the most compelling undeveloped gold assets globally
Lode Gold Enters into Exclusive LOI with a Mining Company to Advance Fremont Gold Project